Literature DB >> 16558072

Low-Temperature-Adapted Influenza A2/AA/6/60 Virus Vaccine in Man.

T Kitayama1, Y Togo, R B Hornick, W T Friedwald.   

Abstract

Volunteers inoculated nasopharyngeally with liver A2/AA/6/60 virus grown in primary bovine kidney cell cultures at 25 C were asymptomatic but developed significant serum and respiratory secretory antibody responses. Viruses were not recovered from these volunteers who had a low or moderate level of prevaccination antibody titers.

Entities:  

Year:  1973        PMID： 16558072      PMCID： PMC422647          DOI： 10.1128/iai.7.1.119-122.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  2 in total

1.  Adaptation and growth characteristics of influenza virus at 25 degrees c.

Authors:  H F Maassab
Journal:  Nature       Date:  1967-02-11       Impact factor: 49.962

2.  Biologic and immunologic characteristics of cold-adapted influenza virus.

Authors:  H F Maassab
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422
  2 in total
  8 in total

1.  Chemically-induced temperature sensitive mutants of dengue virus type 2. I. Isolation and partial characterization.

Authors:  G C Tarr; A S Lubiniecki
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

2.  Chemically induced temperature-sensitive mutants of dengue virus type 2: comparison of temperature sensitivity in vitro with infectivity suckling mice, hamsters, and rhesus monkeys.

Authors:  G C Tarr; A S Lubiniecki
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus.

Authors:  A Lazar; N Okabe; P F Wright
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

5.  Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.

Authors:  B R Murphy; M B Rennels; R G Douglas; R F Betts; R B Couch; T R Cate; R M Chanock; A P Kendal; H F Maassab; S Suwanagool; S B Sotman; L A Cisneros; W C Anthony; D R Nalin; M M Levine
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

6.  Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets.

Authors:  Grace L Chen; Elaine W Lamirande; Hong Jin; George Kemble; Kanta Subbarao
Journal:  Virology       Date:  2009-12-24       Impact factor: 3.616

7.  An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.

Authors:  Kawsar R Talaat; Ruth A Karron; Philana H Liang; Bridget A McMahon; Catherine J Luke; Bhagvanji Thumar; Grace L Chen; Ji-Young Min; Elaine W Lamirande; Hong Jin; Kathy L Coelingh; George W Kemble; Kanta Subbarao
Journal:  Influenza Other Respir Viruses       Date:  2012-03-14       Impact factor: 4.380

Review 8.  Influenza A in Bovine Species: A Narrative Literature Review.

Authors:  Chithra C Sreenivasan; Milton Thomas; Radhey S Kaushik; Dan Wang; Feng Li
Journal:  Viruses       Date:  2019-06-17       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.